Y. Allanore

Arsenic trioxide demonstrates efficacy in a mouse model of preclinical systemic sclerosis

J. Avouac, C. Guignabert, R. Thuillet, 2023, Arthritis Research & Therapy.

Relevance of circulating Semaphorin 4A for rheumatoid arthritis response to treatment

T. Barnetche, J. Avouac, M. Truchetet, 2023, Scientific reports.

Tocilizumab for multirefractory adult-onset Still’s disease

B. Saint-Marcoux, M. de Bandt, P. Coquerelle, 2008, Annals of the rheumatic diseases.

Radiological hand involvement in systemic sclerosis

Y. Allanore, J. Avouac, A. Kahan, 2006, Annals of the rheumatic diseases.

Deficiency and altered phenotype of mucosal-associated invariant T cells in systemic sclerosis

J. Avouac, A. Lehuen, L. Beaudoin, 2023, Journal of scleroderma and related disorders.

Effects of oral treatments on exercise capacity in systemic sclerosis related pulmonary arterial hypertension: a meta-analysis of randomised controlled trials

Y. Allanore, J. Avouac, A. Kahan, 2007, Annals of the rheumatic diseases.

Predictors of hypogammaglobulinemia during rituximab maintenance therapy in rheumatoid arthritis: A 12-year longitudinal multi-center study.

M. Dougados, P. Dieudé, C. Roux, 2018, Seminars in arthritis and rheumatism.

Serum protein oxidation in patients with rheumatoid arthritis and effects of infliximab therapy.

D. Borderie, H. Lemaréchal, O. Ekindjian, 2006, Clinica chimica acta; international journal of clinical chemistry.

Association between RANK, RANKL and OPG polymorphisms with ACPA and erosions in rheumatoid arthritis: results from a meta-analysis involving three French cohorts

A. Cambon-Thomsen, P. Dieudé, J. Sibilia, 2016, RMD Open.